Milestone Pharmaceuticals Inc. Inventory, Finished Goods, Net of Reserves
Milestone Pharmaceuticals Inc. (MIST) had Inventory, Finished Goods, Net of Reserves of $377.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-12
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $377.00K.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $213.00K.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $127.00K.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2026-06-30 | $377.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $213.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $127.00K 10-Q · filed 2026-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |